Jonathan A Gelfond (Jonathan Gelfond)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Radical Prostatectomy

Cardiovascular Events

Top Venues

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Nisi Jiang, Catherine J Cheng, Qianqian Liu, Randy Strong, Jonathan A Gelfond, James F Nelson
Deciphering the Timing and Impact of Life-extending Drugs: A Novel Analytic Approach that Differentiates Early, Midlife, and Senescence Phase Efficacies. bioRxiv : the preprint server for biology (2024)
Nisi Jiang, Catherine J Cheng, Qianqian Liu, Randy Strong, Jonathan A Gelfond, James F Nelson
Deciphering the Timing and Impact of Life-extending Drugs: A Novel Analytic Approach that Differentiates Early, Midlife, and Senescence Phase Efficacies. bioRxiv : the preprint server for biology (2024)
Nisi Jiang, Jonathan A Gelfond, Qianqian Liu, Randy Strong, James F Nelson
The Gehan test identifies life-extending compounds overlooked by the log-rank test in the NIA Interventions Testing Program: Metformin, Enalapril, caffeic acid phenethyl ester, green tea extract, and 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride. GeroScience (2024)
Nisi Jiang, Jonathan A Gelfond, Qianqian Liu, Randy Strong, James F Nelson
The Gehan test identifies life-extending compounds overlooked by the log-rank test in the NIA Interventions Testing Program: Metformin, Enalapril, caffeic acid phenethyl ester, green tea extract, and 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride. GeroScience 46 (5) (2024)
Nisi Jiang, Jonathan A Gelfond, Qianqian Liu, Randy Strong, James F Nelson
The Gehan test identifies life-extending compounds overlooked by the log-rank test in the NIA Interventions Testing Program: Metformin, Enalapril, caffeic acid phenethyl ester, green tea extract, and 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride. GeroScience 46 (5) (2024)
Nisi Jiang, Catherine J Cheng, Qianqian Liu, Randy Strong, Jonathan A Gelfond, James F Nelson
Deciphering the Timing and Impact of Life-extending Drugs: A Novel Analytic Approach that Differentiates Early, Midlife, and Senescence Phase Efficacies. bioRxiv : the preprint server for biology (2024)
Nisi Jiang, Jonathan A Gelfond, Qianqian Liu, Randy Strong, James F Nelson
The Gehan test identifies life-extending compounds overlooked by the log-rank test in the NIA Interventions Testing Program: Metformin, Enalapril, caffeic acid phenethyl ester, green tea extract, and 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride. GeroScience (2024)
Nisi Jiang, Jonathan A Gelfond, Qianqian Liu, Randy Strong, James F Nelson
The Gehan test identifies life-extending compounds overlooked by the log-rank test in the NIA Interventions Testing Program: Metformin, Enalapril, caffeic acid phenethyl ester, green tea extract, and 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride. GeroScience 46 (5) (2024)
Nisi Jiang, Catherine J Cheng, Qianqian Liu, Randy Strong, Jonathan A Gelfond, James F Nelson
Deciphering the Timing and Impact of Life-extending Drugs: A Novel Analytic Approach that Differentiates Early, Midlife, and Senescence Phase Efficacies. bioRxiv : the preprint server for biology (2024)
Jonathan A Gelfond, Brian Hernandez, Martin Goros, Joseph G Ibrahim, Ming-Hui Chen, Wei Sun, Robin J Leach, Michael W Kattan, Ian M Thompson, Donna Pauler Ankerst, Michael Liss
Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials. BMC urology 22 (1) (2022)